These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37260205)
1. [Non-Alcoholic Fatty Liver Disease and Diabetes: the bad marriage]. Nascè A; Memaj P; Jornayvaz FR Rev Med Suisse; 2023 May; 19(829):1090-1093. PubMed ID: 37260205 [TBL] [Abstract][Full Text] [Related]
2. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499 [TBL] [Abstract][Full Text] [Related]
3. The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. Cariou B Diabetes Obes Metab; 2022 Feb; 24 Suppl 2():15-27. PubMed ID: 35014161 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. Hydes TJ; Summers N; Brown E; Alam U; Thomaides-Brears H; Wilding JPH; Cuthbertson DJ Diabet Med; 2020 Nov; 37(11):1793-1806. PubMed ID: 32619031 [TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Lee BW; Lee YH; Park CY; Rhee EJ; Lee WY; Kim NH; Choi KM; Park KG; Choi YK; Cha BS; Lee DH; Diabetes Metab J; 2020 Jun; 44(3):382-401. PubMed ID: 32431115 [TBL] [Abstract][Full Text] [Related]
6. Approach to the Patient With Nonalcoholic Fatty Liver Disease. Belfort-DeAguiar R; Lomonaco R; Cusi K J Clin Endocrinol Metab; 2023 Jan; 108(2):483-495. PubMed ID: 36305273 [TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Cusi K; Sanyal AJ; Zhang S; Hartman ML; Bue-Valleskey JM; Hoogwerf BJ; Haupt A Diabetes Obes Metab; 2017 Nov; 19(11):1630-1634. PubMed ID: 28417532 [TBL] [Abstract][Full Text] [Related]
8. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese. Strey CBM; de Carli LA; Fantinelli M; Gobbato SS; Bassols GF; Losekann A; Coral GP Ann Hepatol; 2018 July - August ,; 17(4):585-591. PubMed ID: 29893699 [TBL] [Abstract][Full Text] [Related]
10. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). Tanase DM; Gosav EM; Costea CF; Ciocoiu M; Lacatusu CM; Maranduca MA; Ouatu A; Floria M J Diabetes Res; 2020; 2020():3920196. PubMed ID: 32832560 [TBL] [Abstract][Full Text] [Related]
11. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. Leoni S; Tovoli F; Napoli L; Serio I; Ferri S; Bolondi L World J Gastroenterol; 2018 Aug; 24(30):3361-3373. PubMed ID: 30122876 [TBL] [Abstract][Full Text] [Related]
12. Steatosis and NASH in type 2 diabetes. Hu M; Phan F; Bourron O; Ferré P; Foufelle F Biochimie; 2017 Dec; 143():37-41. PubMed ID: 29097281 [TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. Kuchay MS; Choudhary NS; Mishra SK; Misra A Diabetes Metab Syndr; 2020; 14(6):2233-2239. PubMed ID: 33336648 [TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? Schröder B; Kahl S; Roden M Liver Int; 2021 Jun; 41 Suppl 1():105-111. PubMed ID: 34155798 [TBL] [Abstract][Full Text] [Related]
15. Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis. Kuchay MS; Misra A Diabetes Metab Syndr; 2022 Mar; 16(3):102446. PubMed ID: 35259705 [TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes. de Vries M; El-Morabit F; van Erpecum KJ; Westerink J; Bac ST; Kaasjager HAHK; de Valk HW Eur J Intern Med; 2022 Jun; 100():77-82. PubMed ID: 35387749 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982 [TBL] [Abstract][Full Text] [Related]
19. What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? Doumas M; Imprialos K; Stavropoulos K; Athyros VG Curr Vasc Pharmacol; 2019; 17(5):425-428. PubMed ID: 31418344 [TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? Firneisz G World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]